Advances in the Treatment of Immune Thrombocytopenia: Strategies for Optimizing Clinical and Patient Outcomes | PTCE Pharmacy Connect

Educational Objectives Outline current guideline recommendations and strategies pharmacists can implement for the management of immune thrombocytopenia (ITP) Recall the efficacy and safety of emerging agents for the treatment of ITP   Moderator: Anthony J. Perissinotti, PharmD, BCOP Hematology Clinical Pharmacist Specialist Clinical Team Leader Hematology/Oncology Adjunct Clinical Assistant Professor University of Michigan – Michigan Medicine Ann Arbor, Michigan   Faculty: Lisa Charneski, PharmD, BCPS Assistant Dean for Academic Affairs Philadelphia College of Pharmacy Associate Professor of Clinical Pharmacy Department of Pharmacy Practice Saint Joseph’s University Philadelphia, Pennsylvania     Anthony J. Perissinotti, PharmD, BCOP has the following relevant financial relationships with commercial interests to disclose: Consultant: AbbVie, BeiGene, Janssen   Lisa Charneski, PharmD, BCPS, has no relevant financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal activity number 0290-0000-22-608-H01-P. The activity is available for CE credit through December 19, 2023.   This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc. To claim CE credit for this activity, please visit the link below: https://www.pharmacytimes.org/courses/advances-in-the-treatment-of-immune-thrombocytopenia-strategies-for-optimizing-clinical-and-patient-outcomes